Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD of bentracimab in healthy volunteers
NCT03492385Phase 1Completed
- Sponsor
- SFJ Pharmaceuticals
- Start
- Apr 2018
- Primary completion
- Sep 2018
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bentracimab in hemorrhage, sponsored by SFJ Pharmaceuticals. Primary endpoints: Number of Participants With Adverse Events, Number of Participants With Clinically Significant Laboratory Abnormalities at 30 Days and 6 more. Started Apr 2018; status: completed.
02
Drugs
bentracimab
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT03492385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03492385.